Age‐related changes in the striatal dopaminergic system in the living brain: A multiparametric PET study in conscious monkeys
- 26 April 2002
- Vol. 45 (1) , 38-45
- https://doi.org/10.1002/syn.10082
Abstract
In the present study, age‐related changes in the striatal dopaminergic system were examined in the living brains of conscious young (6.2 ± 1.5 years old) and aged (20.2 ± 2.6 years old) monkeys (Macaca mulatta) using positron emission tomography (PET). L‐[β‐11C]DOPA and [11C]β‐CFT were applied to determine dopamine presynaptic functions such as synthesis rate and transporter (DAT) availability, respectively. Striatal dopamine D1‐ (D1R) and D2‐like receptor (D2R) binding were measured with [11C]SCH23390 and [11C]raclopride, respectively. Although the markers of presynaptic terminals showed parallel age‐related declines, the reduction of dopamine synthesis rate measured with L‐[β‐11C]DOPA was slightly smaller than that of DAT determined with [11C]β‐CFT. The binding of [11C]raclopride to D2R in vivo was significantly reduced with aging, while that of [11C]SCH23390 to D1R showed no such marked age‐related reduction. When the DAT inhibitor GBR12909 (0.5 and 5 mg/kg) was administered, DAT availability, dopamine synthesis, and D2R binding were significantly decreased in a dose‐dependent manner in both age groups; however, the degrees of the decreases in these parameters were significantly higher in young rather than in aged animals. Dopamine concentration in the striatal extracellular fluid (ECF), as measured by microdialysis, was increased by administration of GBR12909 in a dose‐dependent manner and the degree of the increase in dopamine level decreased with age. These results demonstrate that age‐related changes of dopamine neuronal functions were not limited to the resting condition but were also seen in the functional responses to the neurotransmitter modulation. Synapse 45:38–45, 2002.Keywords
This publication has 54 references indexed in Scilit:
- Ketamine alters the availability of striatal dopamine transporter as measured by [11C]β‐CFT and [11C]β‐CIT‐FE in the monkey brainSynapse, 2001
- Facilitation of dopaminergic neural transmission does not affect [11C]SCH23390 binding to the striatal D1 dopamine receptors, but the facilitation enhances phosphodiesterase type‐IV activity through D1 receptors: PET studies in the conscious monkey brainSynapse, 2001
- Effects of aging on 5‐HT1A receptors and their functional response to 5‐HT1a agonist in the living brain: PET study with [carbonyl‐11C]WAY‐100635 in conscious monkeysSynapse, 2001
- [18F]FDOPA and [18F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's diseaseSynapse, 2001
- Evaluation of novel PET ligands (+)N-[11C]methyl-3-piperidyl benzilate ([11C](+)3-MPB) and its stereoisomer [11C](-)3-MPB for muscarinic cholinergic receptors in the conscious monkey brain: A PET study in comparison with [11C]4-MPBSynapse, 2000
- Age-related reduction of [11C]MDL100,907 binding to central 5-HT2A receptors:: PET study in the conscious monkey brainBrain Research, 2000
- Ketamine decreased striatal [11C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: Multiparametric PET studies combined with microdialysis analysisSynapse, 2000
- Estimation of regional cerebral utilization of [11C]-L-3, 4-dihydroxy-phenylalanine (DOPA) in the primate by positron emission tomographyActa Neurologica Scandinavica, 1992
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomographyInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986